Raptor Pharmaceutical Corp.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Raptor Pharmaceutical Corp.
Upcoming user fee goal dates include AstraZeneca’s tremelimumab, Amicus’ AT-GAA, and drug delivery technology-driven NDAs from Supernus/US Worldmeds and scPharmaceuticals
The US FDA says a Philips recall of more than 17 million masks worn with some recalled breathing machines raises further safety concerns about other medical devices manufactured by the company.
Philips Respironics has recalled more of its BiPAP machines, this time due to the potential for plastic contaminants to be inhaled or shut down the machine.
- Site Specific
- Drug Delivery
- Large Molecule
- Other Names / Subsidiaries
- Encode Pharmaceuticals, Inc.
- TorreyPines Therapeutics, Inc. (Neurogenetics Inc.)